Urgent recall: 3 million eye drop bottles recalled after FDA sterility warning - are you using it?

A major nationwide recall of eye care products has been announced in the United States, impacting over 3 million bottles and initiating safety challenges among consumers. According to the U.S. Food and Drug Administration, a California-based pharmaceutical firm is pulling millions of units from the market due to possible sterility concerns.

Recall initiated over sterility concerns

The FDA reports that K.C. Pharmaceuticals, Inc., based out of Pomona, California, is voluntarily recalling several eye drops distributed in the country. The stated cause for the recall is a “lack of assurance of sterility” in the items.


The agency highlighted that this classification does not automatically confirm contamination, but suggests that the manufacturer cannot ensure that the products consistently meet sterility standards needed to prevent infection-causing microbes in production.

Classified as “Class II” recall

The FDA stated that the eye drops were supplied by companies like Kroger, Walgreens, H-E-B, Military Exchanges, and others. The agency assigned the recall the ranking of a “Class II” recall, meaning exposure to the product could result in temporary or reversible health challenges.

Over 3.1 million bottles affected

The company is recalling over 3.1 million eye drop products in various labels and sizes. According to the FDA’s enforcement report, the impacted products are:

• 182,000 bottles of Sterile Eye Drops AC
  
• 303,000 bottles of Eye Drops Advanced Relief
  
• 1,024,000 bottles of Dry Eye Relief Eye Drops
  
• 245,000 bottles of Ultra Lubricating Eye Drops
  
• 378,000 bottles of Sterile Eye Drops Original Formula
  
• 315,000 bottles of Sterile Eye Drops Redness Lubricant
  
• 74,000 bottles of Sterile Eye Drops Soothing Tears
  
• 590,000 bottles of Artificial Tears Sterile Lubricant Eye Drops
  

In total, 3,111,072 bottles were affected.

Timeline of the recall

The recall was initiated on March 3 and later categorized on March 31. On March 31, the FDA issued a report confirming that millions of bottles were recalled for “Lack of Assurance of Sterility.”

The FDA revealed the nationwide recall publicly on April 2, 2026. Consumers can review comprehended details that include lot codes and UPC numbers, in the FDA’s enforcement report to check whether their product is impacted.

What consumers should do

Health authorities advise users to:

• Verify product labels and lot numbers carefully
  
• Stop using any recalled products immediately
  
• Return or dispose of impacted products
  
• Seek medical attention if symptoms such as irritation or vision issues happens
  

With millions of bottles impacted, the FDA’s action emphasizes ongoing concerns regarding quality control in widely used eye care products and the significance of vigilance when it's about consumer safety.

FAQs:

Q1. What is this recall about?
It involves millions of eye drop bottles pulled from the market. The issue relates to possible sterility concerns during manufacturing.

Q2. Why were the eye drops recalled?
The products had a “lack of assurance of sterility.” This means the company could not confirm they were free from contamination.